Samsrita Labs board to consider draft Scheme of Reorganization

1 min read     Updated on 29 Jun 2026, 08:27 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Samsrita Labs Limited has scheduled a board meeting for July 4, 2026, to consider a draft Scheme of Reorganization and share capital rearrangement. The trading window is closed from June 30 until 48 hours post-meeting. The window will also remain closed until 48 hours after the Q1 unaudited results are declared.

powered bylight_fuzz_icon
44290633

*this image is generated using AI for illustrative purposes only.

Samsrita Labs Limited will hold a board meeting on July 4, 2026, to consider a draft Scheme of Reorganization and the rearrangement of share capital. The meeting is scheduled to take place at the company's registered office in Hyderabad. The board will also discuss any other business with the permission of the Chair.

In compliance with Regulation 9 of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the company's securities has been closed since June 30, 2026. This closure applies to all connected persons, officers, designated employees, insiders, directors, and their immediate relatives. The window will remain shut until 48 hours after the conclusion of the board meeting.

Additionally, the company stated that the trading window will continue to stay closed until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. This measure is part of the company's Code of Conduct for Prevention of Insider Trading, which is framed in accordance with SEBI regulations.

The intimation was signed by K.N.V. Narendra Kumar, Whole-time Director & CFO of Samsrita Labs Limited. The company is listed on BSE Limited and Metropolitan Stock Exchange of India Limited with scrip code 539267 and symbol SAMSRITA, respectively.

Key Meeting Details

Detail Information
Meeting Date July 4, 2026
Agenda Consider draft Scheme of Reorganization/Rearrangement of Share Capital
Location Registered Office, Hyderabad
Trading Window Closure From June 30, 2026, until 48 hours after board meeting

Historical Stock Returns for Samsrita Labs

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+17.10%-14.40%-26.48%-22.94%-55.82%

What specific form of corporate reorganization is the board likely to propose, and will it involve mergers, demergers, or a consolidation of subsidiaries?

How will the rearrangement of share capital impact existing shareholders' equity and the overall capital structure of the company?

What strategic rationale is driving the reorganization, and how does it align with the company's long-term growth objectives?

Samsrita Labs reports FY26 net loss, writes off receivables

1 min read     Updated on 29 May 2026, 07:08 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Samsrita Labs Limited reported a net loss of ₹11.87 lakh for Q4FY26 and ₹868.60 lakh for the full fiscal year FY26. The board approved the write-off of ₹2.09 crore in trade receivables from M/s Mangala Savitri Bizcon Private Limited and ₹3.15 lakh in sundry creditors. M/s Tungala & Co. were appointed as internal auditors for FY 2026-27.

powered bylight_fuzz_icon
41006250

*this image is generated using AI for illustrative purposes only.

Samsrita Labs Limited reported a net loss of ₹11.87 lakh for the quarter ended March 31, 2026, and a net loss of ₹868.60 lakh for the full fiscal year FY26. The company's board approved the audited financial results for the quarter and year ended March 31, 2026, at a meeting held on May 29, 2026.

Financial Performance

For the quarter ended March 31, 2026, the company reported total income of ₹4.96 lakh, comprising revenue from operations of ₹1.81 lakh and other income of ₹3.15 lakh. Total expenses for the quarter stood at ₹16.83 lakh. For the full year FY26, total income was ₹4.96 lakh against total expenses of ₹873.56 lakh, resulting in a net loss of ₹868.60 lakh.

Key Board Decisions

The board approved the write-off of long outstanding trade receivables and doubtful debts amounting to ₹2,08,99,089 due from M/s Mangala Savitri Bizcon Private Limited. Additionally, the board approved the write-off of long outstanding sundry creditors amounting to ₹3,14,676 as they are no longer payable. The board appointed M/s Tungala & Co., Chartered Accountants, as the internal auditors for FY 2026-27.

Financial Summary

Particulars Q4FY26 (₹ in Lakhs) FY26 (₹ in Lakhs)
Revenue from Operations 1.81 1.81
Total Income 4.96 4.96
Total Expenses 16.83 873.56
Net Profit/(Loss) (11.87) (868.60)

The statutory auditors, M/s MGR & Co., issued an unmodified opinion on the audited financial results. The intimation was submitted to the exchanges in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Samsrita Labs

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+17.10%-14.40%-26.48%-22.94%-55.82%

What specific strategies will management implement to reverse the trend of mounting losses and improve operational revenue in FY27?

How will the significant write-off of trade receivables from M/s Mangala Savitri Bizcon impact the company's cash flow and working capital management moving forward?

Does the board anticipate further write-offs of doubtful debts or bad assets in the upcoming fiscal year?

More News on Samsrita Labs

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-22.94%